SPINAL ANAESTHESIA IN A PATIENT WITH HUNTINGTON’S DISEASE – A CASE REPORT

Authors

  • Jasmina Markovič Klinični oddelek za anesteziologijo in intenzivno terapijo operativnih strok Klinični center Zaloška 7 1525 Ljubljana
  • Vesna Novak-Jankovič Klinični oddelek za anesteziologijo in intenzivno terapijo operativnih strok Klinični center Zaloška 7 1525 Ljubljana

Keywords:

chorea, femoral fracture, anaesthesia, 0.5% bupivacain, operation

Abstract

Background. Huntington’s disease is a rare (estimated frequency of 1:10,000–15,000) autosomal dominant neurodegenerative disease. Anaesthetic experience with these patients is limited.

Case description. A case of spinal anaesthesia of 62-year-old man with progressed stage of Huntington’s disease is described. An operation was made because of subtrochanteric fracture of the right femur. Spinal anaesthesia was done briefly and without any technical problems (needle G25, 3 ml of 0.5% isobaric bupivacain). So the choreatic movements of the legs were interrupted, and the movements of the upper part of the body with droperidol 2.5 mg intravenously. The surgical conditions were optimal. The operation was conducted without complications and finished within 90 minutes. The postoperative period was without any special problems.

Conclusions. We would like to contribute our part to the anaesthetic experience in patients with Huntington’s disease and to show that spinal anaesthesia is suitable and safe also for procedure longer than one our.

Downloads

Download data is not yet available.

References

Riley DE, Lang AE. Movement disorders. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD. Neurology in Clinical practice. 3rd ed. Boston: Butterworth Heinemann, 2000: 1914–6.

Davies DD. Abnormal response to anaesthesia in a case of Huntington’s chorea. A case report. Br J Anaesth 1966; 38: 490–1.

Gualandi W, Bonfati G. Un caso di apnea prolungata in corea di Huntington. Acta Anaesthesiologica (Padova) 1968; 19: 235–8.

Rodrigo MRC. Huntington’s chorea: midazolam, a suitable induction agent? Br J Anaesth 1987; 59: 388–9.

Stoelting RK, Dierdoff SF, McCammon RL. Anaesthesia and coexisting disease. 2nd ed. New York: Churchill Livingstone, 1998: 307–7.

Kaufman MA, Erb T. Propofol for patients with Huntington’s chorea? Anaesthesia 1990; 45: 889–90.

Nagele P, Hammerle AF. Sevoflurane and mivacurium in a patient with Huntington’s chorea. Br J Anaesth 2000; 85: 320–1.

Kulemeka G, Mendonca C. Huntington’s chorea: use of rocuronium. Anaesthesia 2001; 56: 1019–9.

Fernandez G, Sanchez MP, Ugalde AJ, Hernandez CMG. Spinal anaesthesia in a patient with Huntington’s chorea. Anaesthesia 1997; 52: 391–1.

Propert DN. Pseudocholinesterase activity in mentally ill patients. British Journal of Psychiatry 1979; 134: 477–81.

Soar J, Matheson KH. A safe anaesthetic in Huntington’s disease? Anaesthesia 1993; 48: 743–4.

Farina J, Rauscher LA. Anaesthesia and Huntington’s chorea. A report of two cases. Br J Anaesth 1977; 49: 1167–8.

Browne MG, Cross R. Huntington’s chorea. Br J Anaesth 1981; 53: 1367–7.

Katz J, Benumof JL, Kadis LB. Anaesthesia and uncommon diseases. 3rd ed. Philadelphia, London, Toronto: Saunders, 1990: 560–3.

Issue

Section

Professional Article

How to Cite

1.
SPINAL ANAESTHESIA IN A PATIENT WITH HUNTINGTON’S DISEASE – A CASE REPORT. ZdravVestn [Internet]. 2002 Jul. 8 [cited 2024 Nov. 2];71(7/8). Available from: https://vestnik.szd.si/index.php/ZdravVest/article/view/1608

Most read articles by the same author(s)